Literature DB >> 19409521

IFRD1 is a candidate gene for SMNA on chromosome 7q22-q23.

Zoran Brkanac1, David Spencer, Jay Shendure, Peggy D Robertson, Mark Matsushita, Tiffany Vu, Thomas D Bird, Maynard V Olson, Wendy H Raskind.   

Abstract

We have established strong linkage evidence that supports mapping autosomal-dominant sensory/motor neuropathy with ataxia (SMNA) to chromosome 7q22-q32. SMNA is a rare neurological disorder whose phenotype encompasses both the central and the peripheral nervous system. In order to identify a gene responsible for SMNA, we have undertaken a comprehensive genomic evaluation of the region of linkage, including evaluation for repeat expansion and small deletions or duplications, capillary sequencing of candidate genes, and massively parallel sequencing of all coding exons. We excluded repeat expansion and small deletions or duplications as causative, and through microarray-based hybrid capture and massively parallel short-read sequencing, we identified a nonsynonymous variant in the human interferon-related developmental regulator gene 1 (IFRD1) as a disease-causing candidate. Sequence conservation, animal models, and protein structure evaluation support the involvement of IFRD1 in SMNA. Mutation analysis of IFRD1 in additional patients with similar phenotypes is needed for demonstration of causality and further evaluation of its importance in neurological diseases.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19409521      PMCID: PMC2680994          DOI: 10.1016/j.ajhg.2009.04.008

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  27 in total

1.  Early gene regulation by nerve growth factor in PC12 cells: induction of an interferon-related gene.

Authors:  F Tirone; E M Shooter
Journal:  Proc Natl Acad Sci U S A       Date:  1989-03       Impact factor: 11.205

2.  The Val-210-Ile pathogenic Creutzfeldt-Jakob disease mutation increases both the helical and aggregation propensities of a sequence corresponding to helix-3 of PrP(C).

Authors:  A J Thompson; K J Barnham; R S Norton; C J Barrow
Journal:  Biochim Biophys Acta       Date:  2001-01-12

3.  Missense mutations in the regulatory domain of PKC gamma: a new mechanism for dominant nonepisodic cerebellar ataxia.

Authors:  Dong-Hui Chen; Zoran Brkanac; Christophe L M J Verlinde; Xiao-Jian Tan; Laura Bylenok; David Nochlin; Mark Matsushita; Hillary Lipe; John Wolff; Magali Fernandez; P J Cimino; Thomas D Bird; Wendy H Raskind
Journal:  Am J Hum Genet       Date:  2003-03-17       Impact factor: 11.025

4.  A gene atlas of the mouse and human protein-encoding transcriptomes.

Authors:  Andrew I Su; Tim Wiltshire; Serge Batalov; Hilmar Lapp; Keith A Ching; David Block; Jie Zhang; Richard Soden; Mimi Hayakawa; Gabriel Kreiman; Michael P Cooke; John R Walker; John B Hogenesch
Journal:  Proc Natl Acad Sci U S A       Date:  2004-04-09       Impact factor: 11.205

5.  A mutation in the nerve growth factor beta gene (NGFB) causes loss of pain perception.

Authors:  Elisabet Einarsdottir; Anna Carlsson; Jan Minde; Göran Toolanen; Olle Svensson; Göran Solders; Gösta Holmgren; Dan Holmberg; Monica Holmberg
Journal:  Hum Mol Genet       Date:  2004-02-19       Impact factor: 6.150

6.  Clinical features of Creutzfeldt-Jakob disease with V180I mutation.

Authors:  K Jin; Y Shiga; S Shibuya; K Chida; Y Sato; H Konno; K Doh-ura; T Kitamoto; Y Itoyama
Journal:  Neurology       Date:  2004-02-10       Impact factor: 9.910

7.  TIS gene expression in cultured rat astrocytes: multiple pathways of induction by mitogens.

Authors:  A T Arenander; R W Lim; B C Varnum; R Cole; J de Vellis; H R Herschman
Journal:  J Neurosci Res       Date:  1989-07       Impact factor: 4.164

8.  Muscle regeneration and myogenic differentiation defects in mice lacking TIS7.

Authors:  Santhosh K Vadivelu; Robert Kurzbauer; Benjamin Dieplinger; Margit Zweyer; Ralf Schafer; Anton Wernig; Ilja Vietor; Lukas A Huber
Journal:  Mol Cell Biol       Date:  2004-04       Impact factor: 4.272

9.  TIS7 interacts with the mammalian SIN3 histone deacetylase complex in epithelial cells.

Authors:  Ilja Vietor; Santhosh K Vadivelu; Nikolaus Wick; Robert Hoffman; Matt Cotten; Christian Seiser; Irene Fialka; Winfried Wunderlich; Astrid Haase; Gabriela Korinkova; Gerald Brosch; Lukas A Huber
Journal:  EMBO J       Date:  2002-09-02       Impact factor: 11.598

10.  Cloning of the human interferon-related developmental regulator (IFRD1) gene coding for the PC4 protein, a member of a novel family of developmentally regulated genes.

Authors:  P Buanne; B Incerti; D Guardavaccaro; V Avvantaggiato; A Simeone; F Tirone
Journal:  Genomics       Date:  1998-07-15       Impact factor: 5.736

View more
  16 in total

1.  Potential genetic risk factors for chronic TMD: genetic associations from the OPPERA case control study.

Authors:  Shad B Smith; Dylan W Maixner; Joel D Greenspan; Ronald Dubner; Roger B Fillingim; Richard Ohrbach; Charles Knott; Gary D Slade; Eric Bair; Dustin G Gibson; Dmitri V Zaykin; Bruce S Weir; William Maixner; Luda Diatchenko
Journal:  J Pain       Date:  2011-11       Impact factor: 5.820

Review 2.  Applications of targeted gene capture and next-generation sequencing technologies in studies of human deafness and other genetic disabilities.

Authors:  Xi Lin; Wenxue Tang; Shoeb Ahmad; Jingqiao Lu; Candice C Colby; Jason Zhu; Qing Yu
Journal:  Hear Res       Date:  2012-01-14       Impact factor: 3.208

Review 3.  Massively parallel sequencing and rare disease.

Authors:  Sarah B Ng; Deborah A Nickerson; Michael J Bamshad; Jay Shendure
Journal:  Hum Mol Genet       Date:  2010-09-15       Impact factor: 6.150

4.  Analysis of DNA sequence variants detected by high-throughput sequencing.

Authors:  David R Adams; Murat Sincan; Karin Fuentes Fajardo; James C Mullikin; Tyler M Pierson; Camilo Toro; Cornelius F Boerkoel; Cynthia J Tifft; William A Gahl; Tom C Markello
Journal:  Hum Mutat       Date:  2012-02-28       Impact factor: 4.878

5.  Next-generation sequencing of a 40 Mb linkage interval reveals TSPAN12 mutations in patients with familial exudative vitreoretinopathy.

Authors:  Konstantinos Nikopoulos; Christian Gilissen; Alexander Hoischen; C Erik van Nouhuys; F Nienke Boonstra; Ellen A W Blokland; Peer Arts; Nienke Wieskamp; Tim M Strom; Carmen Ayuso; Mauk A D Tilanus; Sanne Bouwhuis; Arijit Mukhopadhyay; Hans Scheffer; Lies H Hoefsloot; Joris A Veltman; Frans P M Cremers; Rob W J Collin
Journal:  Am J Hum Genet       Date:  2010-02-12       Impact factor: 11.025

Review 6.  Revisiting Mendelian disorders through exome sequencing.

Authors:  Chee-Seng Ku; Nasheen Naidoo; Yudi Pawitan
Journal:  Hum Genet       Date:  2011-02-18       Impact factor: 4.132

7.  Targeted next-generation sequencing appoints c16orf57 as clericuzio-type poikiloderma with neutropenia gene.

Authors:  Ludovica Volpi; Gaia Roversi; Elisa Adele Colombo; Nico Leijsten; Daniela Concolino; Andrea Calabria; Maria Antonietta Mencarelli; Michele Fimiani; Fabio Macciardi; Rolph Pfundt; Eric F P M Schoenmakers; Lidia Larizza
Journal:  Am J Hum Genet       Date:  2009-12-10       Impact factor: 11.025

8.  Identification of rare variants from exome sequence in a large pedigree with autism.

Authors:  E E Marchani; N H Chapman; C Y K Cheung; K Ankenman; I B Stanaway; H H Coon; D Nickerson; R Bernier; Z Brkanac; E M Wijsman
Journal:  Hum Hered       Date:  2013-04-11       Impact factor: 0.444

9.  Transcriptional Modulator Ifrd1 Regulates Osteoclast Differentiation through Enhancing the NF-κB/NFATc1 Pathway.

Authors:  Takashi Iezaki; Kazuya Fukasawa; Gyujin Park; Tetsuhiro Horie; Takashi Kanayama; Kakeru Ozaki; Yuki Onishi; Yoshifumi Takahata; Yukari Nakamura; Takeshi Takarada; Yukio Yoneda; Takashi Nakamura; Jean Vacher; Eiichi Hinoi
Journal:  Mol Cell Biol       Date:  2016-09-12       Impact factor: 4.272

10.  Identification of IFRD1 variant in a Han Chinese family with autosomal dominant hereditary spastic paraplegia associated with peripheral neuropathy and ataxia.

Authors:  Pengfei Lin; Dong Zhang; Guangrun Xu; Chuanzhu Yan
Journal:  J Hum Genet       Date:  2018-01-23       Impact factor: 3.172

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.